DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹2,248 Cr | ₹1,755 Cr | ₹1,539 Cr | ₹2,454 Cr | ₹1,728 Cr |
What is the latest Total Current Liabilities ratio of DIVIS LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹2,248 Cr |
| Mar2024 | ₹1,755 Cr |
| Mar2023 | ₹1,539 Cr |
| Mar2022 | ₹2,454 Cr |
| Mar2021 | ₹1,728 Cr |
How is Total Current Liabilities of DIVIS LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,248 Cr | 28.09 | |
| Mar2024 | ₹1,755 Cr | 14.04 | |
| Mar2023 | ₹1,539 Cr | -37.30 | |
| Mar2022 | ₹2,454 Cr | 42.01 | |
| Mar2021 | ₹1,728 Cr | - | |
Compare Total Current Liabilities of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹162,014.7 Cr | 0.5% | -2.9% | 5.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,470.0 Cr | -0.3% | 3.1% | 2.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,440.0 Cr | 0.1% | 1.4% | 37.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,417.0 Cr | 1.9% | 1.4% | 10.7% | Stock Analytics | |
| CIPLA | ₹101,445.0 Cr | -3.3% | -6.9% | -17% | Stock Analytics | |
| MANKIND PHARMA | ₹82,555.3 Cr | -4.4% | -3.6% | -7.9% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 0.5% |
-2.9% |
5.4% |
| SENSEX | -0% |
-10.7% |
1% |
You may also like the below Video Courses